AC Immune SA annual revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AC Immune SA Revenue Growth & History (ACIU)
AC Immune SA reported CHF3.6M in revenue for fiscal 2025, a decrease of 86.92% from the previous fiscal year.
View full AC Immune SA company overviewAC Immune SA annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF3.6M | −CHF23.7M | −86.92% |
| 2024 | 2024-12-31 | CHF27.3M | CHF12.5M | +84.51% |
| 2023 | 2023-12-31 | CHF14.8M | CHF10.9M | +276.14% |
| 2022 | 2022-12-31 | CHF3.9M | CHF3.9M | — |
| 2021 | 2021-12-31 | CHF0 | −CHF15.4M | −100.00% |
| 2020 | 2020-12-31 | CHF15.4M | −CHF95.0M | −86.03% |
| 2019 | 2019-12-31 | CHF110.5M | CHF103.5M | +1498.03% |
| 2018 | 2018-12-31 | CHF6.9M | −CHF13.3M | −65.88% |
| 2017 | 2017-12-31 | CHF20.3M | −CHF3.0M | −12.75% |
| 2016 | 2016-12-31 | CHF23.2M | −CHF15.9M | −40.61% |
| 2015 | 2015-12-31 | CHF39.1M | — | — |
AC Immune SA quarterly revenue
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q3.21
Q2.22
Q3.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | CHF15.1M | CHF13.8M | +1057.20% |
| Q1 2026 | 2026-03-31 | CHF1.1M | — | — |
| Q4 2025 | 2025-12-31 | CHF338,000 | — | — |
| Q3 2025 | 2025-09-30 | CHF939,000 | — | — |
| Q2 2025 | 2025-06-30 | CHF1.3M | CHF619,000 | +90.10% |
| Q2 2024 | 2024-06-30 | CHF687,000 | CHF687,000 | — |
| Q2 2023 | 2023-06-30 | CHF0 | CHF0 | — |
| Q3 2022 | 2022-09-30 | CHF3.9M | CHF3.9M | — |
| Q2 2022 | 2022-06-30 | CHF0 | — | — |
| Q3 2021 | 2021-09-30 | CHF0 | — | — |
| Q4 2018 | 2018-12-31 | CHF1.4M | −CHF15.0M | −91.46% |
| Q3 2018 | 2018-09-30 | CHF2.3M | CHF1.2M | +114.62% |
| Q2 2018 | 2018-06-30 | CHF2.0M | CHF1.3M | +169.32% |
| Q1 2018 | 2018-03-31 | CHF1.5M | −CHF548,000 | −27.32% |
| Q4 2017 | 2017-12-31 | CHF16.4M | — | — |
| Q3 2017 | 2017-09-30 | CHF1.1M | — | — |
| Q2 2017 | 2017-06-30 | CHF753,000 | — | — |
| Q1 2017 | 2017-03-31 | CHF2.0M | — | — |
AC Immune SA revenue growth trends
Over the last five reported fiscal years, revenue declined from CHF15.4M to CHF3.6M, a compound annual decline of 25.37%. AC Immune SA's latest reported quarter, Q2 2026, generated CHF15.1M in revenue, an increase of 1057.20% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review AC Immune SA source filings ↗